Indications and uses
For Immune Support against flu-like symptoms and lethargy, including: fatigue aches & pains congestion nausea appetite loss low energy
Canova Immune Support
- Manufacturer
- MRL Homeopathic USA LLC | Oasis Health Products, Inc.
- Effective date
- 2013-05-08
- Label type
- HUMAN OTC DRUG LABEL
- Version
- 1
- Source
- full-release
- Hydrated at
- 2026-06-01 02:04:34
Label at a glance#
ProductCanova Immune Support
Active ingredientACONITUM NAPELLUS, APIS MELLIFERA, ARSENIC TRIOXIDE, ASAFETIDA, BARIUM CARBONATE, BRYONIA ALBA ROOT, OYSTER SHELL CALCIUM CARBONATE, CRUDE, CONIUM MACULATUM FLOWERING TOP, IPECAC, LACHESIS MUTA VENOM, LYCOPODIUM CLAVATUM SPORE, PULSATILLA VULGARIS, TOXICODENDRON PUBESCENS LEAF, CASTOR OIL, SILICON DIOXIDE, THUJA OCCIDENTALIS ROOT, VERATRUM ALBUM ROOT
Label structure10 sections
Dosage and administration
Tap the bottom of the bottle on the palm of the hand 15 times before each use. Take 10 drops under the tongue 3 times per day. Do not eat or drink anything 30 minutes prior to and after use.
Contacts and useful links#
Websitewww.canovausa.com
www.canovausa.com
www.canovausa.comLabel contents#
Full prescribing information#
Active ingredient
Aconitum napellus..............20X
Apis mellifica......................19X
Arsenicum album................17X
Asafoetida...........................20X
Baryta carbonica.................20X
Bryonia alba........................14X
Calcarea carbonica..............20X
Conium maculatum.............16X
Ipecacuanha.........................13X
Lachesis mutus....................18X
Lycopodium clavatum.........20X
Pulsatilla nigricans...............13X
Rhus toxicodendron.............17X
Ricinus communis...............14X
Silicea..................................18X
Thuja occidentalis................16X
Veratrum album...................20X
Purpose
Temporarily reduces severity of flu-like symptoms
Uses
For Immune Support against flu-like symptoms and lethargy, including:
- fatigue
- aches & pains
- congestion
- nausea
- appetite loss
- low energy
Warnings
Stop use and ask a doctor if symptoms persist for more than 7 days.
Do not use if tamper resistant seal is broken or missing.
If pregnant or breast-feeding, ask a health professional before use.
Directions
- Tap the bottom of the bottle on the palm of the hand 15 times before each use.
- Take 10 drops under the tongue 3 times per day.
- Do not eat or drink anything 30 minutes prior to and after use.
Other Information
Store at 15-30° C (59-86° F), out of direct sunlight.
Inactive ingredients
citric acid, glycerin, potassium sorbate, purified water, sodium benzoate.
Questions or comments?
Call (702) 990-3897 or visit www.canovausa.com
Developed and Distributed by:
MRL Homeopathic USA LLC
3960 Howard Hughes Parkway, Suite 500
Las Vegas, NV 89189www.canovausa.com
MADE IN THE U.S.A.
Patient Information
When was Canova Immune Support developed?
In the 1960s, Dr. Francisco Canova, an Argentinean medical doctor and trained homeopath, developed a homeopathic medicine, later called Canova Immune Support, for the debilitating effects of a compromised immune system. Canova Immune Support developed a loyal following reaching over 10,000 users by the early 1990s.
What is Canova Immune Support?
Canova Immune Support is a homeopathic medicine made from 17 different plants, mineral and animal ingredients. It provides favorable support to your immune system in your day-to-day activities by boosting the body's immune system and enhancing resistance to immune challenges due to fatigue, exposure to environmental challenges, and stress. Canova Immune Support is a complement, not replacement, to traditional (allopathic) medicine.
Can Canova Immune Support be used to treat recurring illnesses?
For patients with recurring illnesses, Canova Immune Support aims to reduce the intensity and frequency of episodes or outbreaks, as with allergies or herpes, for example.*
What is the main benefit of taking Canova Immune Support?
Canova Immune Support stimulates the human body’s defenses against infection, disease, or other unwanted biological invasion, providing relief for symptoms experienced by people with a weakened immune system, such as fatigue, nausea, appetite loss, and aches and pains. The ultimate and main benefit of Canova Immune Support is the improved quality of life for people fighting incapacitating symptoms, such as the severity of those associated with the flu.*
Can Canova Immune Support be taken in conjunction with other medications?
The extremely small doses of each active homeopathic ingredient of Canova Immune Support assure it is safe and has no known side effects or contraindications. Canova Immune Support can be safely taken with other conventional medicines and is usually recommended as a complement to other treatments.*
Can I give Canova Immune Support to my children?
Homeopathic medicines are generally safe for children. Please see package labeling for specific drug facts and dosage recommendations. For a child under the age specified on the label, please check with a doctor or pharmacist first.
Can I use Canova Immune Support by myself, without a doctor's supervision?
Canova Immune Support may be used for self-diagnosable conditions that do not require a doctor’s supervision. Canova Immune Support is clearly labeled with warnings and directions for use, as per FDA Regulations. Always read and follow label directions when taking Canova without a doctor’s supervision.
Is Canova Immune Support safe to use when pregnant?
As with any medicine, pregnant women should seek the advice of a medical professional before use.
How popular is Canova Immune Support?
Canova Immune Support is currently used by an estimated 30,000 people worldwide.
Has Canova Immune Support been researched?
Several Universities and Research Institutions conducted various research studies on Canova Immune Support and published their results in 16 international life science journals, seven university published papers, and 19 international congress papers.
What is the best way to store Canova Immune Support?
The best way to store Canova Immune Support is away from direct sunlight, TV sets, radios, microwave ovens, cell phones, other electrical appliances and fragrant substances, such as perfumes. It is also important that the bottle be tightly closed after each use.
*This statement has not been approved by the FDA. This product is not intended to treat, cure or prevent any disease.
Questions or comments?
Call (702) 990-3897 or visit www.canovausa.com
Developed and Distributed by:
MRL Homeopathic USA LLC
3960 Howard Hughes Parkway, Suite 500
Las Vegas, NV 89169 www.canovausa.com
MADE IN THE U.S.A.
Package/Label Principal Display Panel
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 63f39a63-5cd1-4016-bd86-2bbb0f6c3139 | Product name | 3 | 20240506 |
| e5a77e9c-c528-733a-173d-914a234c024b | Product name | 5 | 20240506 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 58088-001-01 | 2019-11-27 | C162847 | 48780-1 | 9855d018-e135-cd31-e053-dbdaa90ab51a | CANOVA ® Immune Support |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 58088-001-01 | Canova Immune Support | 1 in 1 CARTON | LIQUID | 1 | 1 | |
| 58088-001-01 | Canova Immune Support | 59 mL in 1 BOTTLE, DROPPER | LIQUID | 59 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| ACONITUM NAPELLUS | ACTIVE INGREDIENT | U0NQ8555JD | 1 | |
| APIS MELLIFERA | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| ARSENIC TRIOXIDE | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| ASAFETIDA | ACTIVE INGREDIENT | W9FZA51AS1 | 1 | |
| BARIUM CARBONATE | ACTIVE INGREDIENT | 6P669D8HQ8 | 1 | |
| BRYONIA ALBA ROOT | ACTIVE INGREDIENT | T7J046YI2B | 1 | |
| CASTOR OIL | ACTIVE INGREDIENT | D5340Y2I9G | 1 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE INGREDIENT | Q28R5GF371 | 1 | |
| IPECAC | ACTIVE INGREDIENT | 62I3C8233L | 1 | |
| LACHESIS MUTA VENOM | ACTIVE INGREDIENT | VSW71SS07I | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE INGREDIENT | C88X29Y479 | 1 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE INGREDIENT | 2E32821G6I | 1 | |
| PULSATILLA VULGARIS | ACTIVE INGREDIENT | I76KB35JEV | 1 | |
| SILICON DIOXIDE | ACTIVE INGREDIENT | ETJ7Z6XBU4 | 1 | |
| THUJA OCCIDENTALIS ROOT | ACTIVE INGREDIENT | 12958C0BR3 | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE INGREDIENT | 6IO182RP7A | 1 | |
| VERATRUM ALBUM ROOT | ACTIVE INGREDIENT | QNS6W5US1Z | 1 | |
| ACONITUM NAPELLUS | ACTIVE MOIETY | U0NQ8555JD | 1 | |
| APIS MELLIFERA | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| ARSENIC CATION (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| ASAFETIDA | ACTIVE MOIETY | W9FZA51AS1 | 1 | |
| BARIUM CATION | ACTIVE MOIETY | V645272HLN | 1 | |
| BRYONIA ALBA ROOT | ACTIVE MOIETY | T7J046YI2B | 1 | |
| CASTOR OIL | ACTIVE MOIETY | D5340Y2I9G | 1 | |
| CONIUM MACULATUM FLOWERING TOP | ACTIVE MOIETY | Q28R5GF371 | 1 | |
| IPECAC | ACTIVE MOIETY | 62I3C8233L | 1 | |
| LACHESIS MUTA VENOM | ACTIVE MOIETY | VSW71SS07I | 1 | |
| LYCOPODIUM CLAVATUM SPORE | ACTIVE MOIETY | C88X29Y479 | 1 | |
| OYSTER SHELL CALCIUM CARBONATE, CRUDE | ACTIVE MOIETY | 2E32821G6I | 1 | |
| PULSATILLA VULGARIS | ACTIVE MOIETY | I76KB35JEV | 1 | |
| SILICON DIOXIDE | ACTIVE MOIETY | ETJ7Z6XBU4 | 1 | |
| THUJA OCCIDENTALIS ROOT | ACTIVE MOIETY | 12958C0BR3 | 1 | |
| TOXICODENDRON PUBESCENS LEAF | ACTIVE MOIETY | 6IO182RP7A | 1 | |
| VERATRUM ALBUM ROOT | ACTIVE MOIETY | QNS6W5US1Z | 1 | |
| CITRIC ACID MONOHYDRATE | INACTIVE INGREDIENT | 2968PHW8QP | 1 | |
| GLYCERIN | INACTIVE INGREDIENT | PDC6A3C0OX | 1 | |
| POTASSIUM SORBATE | INACTIVE INGREDIENT | 1VPU26JZZ4 | 1 | |
| SODIUM BENZOATE | INACTIVE INGREDIENT | OJ245FE5EU | 1 | |
| WATER | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Products#
Every source-derived product name is available through these pages.
- Canova Immune Support
- ACONITUM NAPELLUS
- APIS MELLIFERA
- ARSENIC TRIOXIDE
- ARSENIC CATION (3+)
- ASAFETIDA
- BARIUM CARBONATE
- BARIUM CATION
- BRYONIA ALBA ROOT
- OYSTER SHELL CALCIUM CARBONATE, CRUDE
- CONIUM MACULATUM FLOWERING TOP
- IPECAC
- LACHESIS MUTA VENOM
- LYCOPODIUM CLAVATUM SPORE
- PULSATILLA VULGARIS
- TOXICODENDRON PUBESCENS LEAF
- CASTOR OIL
- SILICON DIOXIDE
- THUJA OCCIDENTALIS ROOT
- VERATRUM ALBUM ROOT
- CITRIC ACID MONOHYDRATE
- GLYCERIN
- POTASSIUM SORBATE
- WATER
- SODIUM BENZOATE
NDC Codes#
| Product NDC | Package NDC |
|---|---|
| 58088-001 | 58088-001-01 |
Ingredients#
Every source-derived ingredient row is available through these pages.
Source Document#
Inactive ingredient matches#
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, EXTENDED RELEASE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | LOTION / TOPICAL | 0.85 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION, CONCENTRATE / INTRAVENOUS | NA | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / TOPICAL | 1971 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRAVENOUS | 225 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GUM, CHEWING / BUCCAL | 230 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION / OPHTHALMIC | 6 %w/v | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION, SOLUTION / INTRAMUSCULAR | 4.8 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | TABLET, COATED / ORAL | 1 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, LIQUID FILLED / ORAL | 185 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / RECTAL | 6.67 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | EMULSION / INTRAVENOUS | 2.2 %w/v | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | PASTE / ORAL | 48 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / SUBCUTANEOUS | 450 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | POWDER, FOR SOLUTION / ORAL | 315 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, EMULSION / INTRAVENOUS | 24100 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / INTRAVENOUS | 396 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION / SUBCUTANEOUS | 26 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | DROPS / ORAL | 300 mg/1ml | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / OPHTHALMIC | 0.03 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TROCHE / ORAL | 12 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / SUBCUTANEOUS | 15 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION / ORAL | 26208 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CREAM / VAGINAL | 60 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | GRANULE, FOR SUSPENSION / ORAL | 80 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRATHECAL | ADJ PH | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAVENOUS | 10 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY, METERED / NASAL | 13 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | GRANULE / ORAL | NA | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE, EXTENDED RELEASE / ORAL | 101 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | SUSPENSION, EXTENDED RELEASE / ORAL | 24 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRA-ARTICULAR | ADJ PH | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION / INTRADERMAL | 1.6 %w/v | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE, COATED / ORAL | 14.21 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | TABLET, DELAYED RELEASE / ORAL | 0.34 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SPRAY / NASAL | 22.3 mg/1ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | AEROSOL / TOPICAL | 3 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SOLUTION / INTRAMUSCULAR | 0.05 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SPRAY / NASAL | 9 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | PASTE, DENTIFRICE / DENTAL | 18 %w/w | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | GEL / TRANSDERMAL | 500 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SUSPENSION, EXTENDED RELEASE / INTRAMUSCULAR | 38 mg | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | SOLUTION / ORAL | 1000 mg/15ml | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUSPENSION, EXTENDED RELEASE / ORAL | 2000 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SYSTEM / TOPICAL | 18144 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | CAPSULE / ORAL | 238 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | INJECTION, SOLUTION / INTRAVENOUS | 15 %w/v | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, CHEWABLE / ORAL | 7 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | ELIXIR / ORAL | 100 mg/5ml | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | PASTE, DENTIFRICE / DENTAL | 0.5 %w/w | ||
| POTASSIUM SORBATE | POTASSIUM SORBATE | 1VPU26JZZ4 | CONCENTRATE / ORAL | 1 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SWAB / TOPICAL | 0.05 %w/w | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | INJECTION / INTRAVENOUS | 2068 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | TABLET, EXTENDED RELEASE / ORAL | 45 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | CAPSULE / ORAL | 3487 mg | ||
| SODIUM BENZOATE | SODIUM BENZOATE | OJ245FE5EU | INJECTION / INTRAVENOUS | 864 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SUPPOSITORY / RECTAL | 440 mg | ||
| CITRIC ACID MONOHYDRATE | CITRIC ACID MONOHYDRATE | 2968PHW8QP | SYSTEM / IONTOPHORESIS | 0.2 mg | ||
| GLYCERIN | GLYCERIN | PDC6A3C0OX | SOLUTION, CONCENTRATE / ORAL | 200 mg/1ml |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| c31e0961-9d66-45d9-bd5e-2b37d078c8e3 | c31e0961-9d66-45d9-bd5e-2b37d078c8e3 | 2013-05-08 | Warnings | c31e0961-9d66-45d9-bd5e-2b37d078c8e3 c31e0961-9d66-45d9-bd5e-2b37d078c8e3 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.